These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 3806984)

  • 1. [Myelodysplastic syndrome: morphological aspects of dysmyelopoiesis].
    Koike T; Takahashi M
    Rinsho Ketsueki; 1986 Sep; 27(9):1752-64. PubMed ID: 3806984
    [No Abstract]   [Full Text] [Related]  

  • 2. [The value of an in vitro method of granulomonocytic colonies for the diagnosis and prognosis of myelodysplastic syndromes].
    Grigoriu G; Puşcariu T; Ursea C; Munteanu N; Butoianu E; Coliţă A; Popp A
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1988; 40(1):61-8. PubMed ID: 2899349
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cytodynamics of myeloid precursors (divisible erythroblasts and granulocytes) in myelodysplastic syndromes].
    Sánchez Fayos J; Outeiriño J; Calabuig T; Prieto E; Pérez-Sánchez I; Lapuente L; Escudero A
    Sangre (Barc); 1985; 30(4-C):698-704. PubMed ID: 4089739
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of dysmyelopoiesis in cats: 34 cases (1996-2005).
    Weiss DJ
    J Am Vet Med Assoc; 2006 Mar; 228(6):893-7. PubMed ID: 16536701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myelodysplasia or myelodysplastic syndrome?
    Giagounidis AA
    Leuk Res; 2009 Aug; 33(8):1019. PubMed ID: 19303635
    [No Abstract]   [Full Text] [Related]  

  • 6. DNA content of granulocytes, monocytes, and lymphocytes in the bone marrow smears of patients with myelodysplastic syndromes.
    Widell S; Hast R; Cox C; Auer G; Bennett JM
    Am J Hematol; 2001 Jun; 67(2):112-8. PubMed ID: 11343383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnosis and treatment strategy for de novo AML with trilineage myelodysplasia].
    Kuriyama K
    Rinsho Ketsueki; 1994 Mar; 35(3):267-71. PubMed ID: 8158847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prognosis in patients with myelodysplastic syndromes based on cytomorphologic and clinico-biologic parameters].
    Belić A; Stefanović N; Pejin D; Mihajlović M; Popović S; Kljajić D; Uzurov V; Spasojević J
    Med Pregl; 1994; 47(7-8):237-42. PubMed ID: 7791674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical, haematological and histomorphological profile of adult myelodysplastic syndrome. Study of 96 cases in a single institute.
    Chatterjee T; Dixit A; Mohapatra M; Tyagi S; Gupta PK; Mishra P; Bhattacharya M; Karan AS; Pati HP; Saxena R; Choudhry VP
    Eur J Haematol; 2004 Aug; 73(2):93-7. PubMed ID: 15245507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Value of the in vitro culture of granulomonocytic germ cells (CFU-GM) in myelodysplastic syndromes].
    Florensa L; Woessner S; Lafuente R; Almarcha J; Sans-Sabrafen J
    Sangre (Barc); 1985; 30(4-C):689-97. PubMed ID: 3867159
    [No Abstract]   [Full Text] [Related]  

  • 11. Trisomy 14 in myelodysplastic syndromes: report of two cases and review of the literature.
    Vasef MA; Murata-Collins JL; Alsabeh R; Medeiros LJ
    Arch Pathol Lab Med; 1998 Jan; 122(1):77-83. PubMed ID: 9448022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Syndrome of abnormal chromatin clumping in leucocytes with a high fraction of bone marrow cells in S-phase and in vitro autonomous growth].
    Vallejo C; García-Marcos MA; Del Cañizo MC; Orfao A; Almeida J; Escribano L; San Miguel JF; Ríos A
    Med Clin (Barc); 1997 Sep; 109(9):340-2. PubMed ID: 9379766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of bone marrow study in diagnosis and prognosis of myelodysplastic syndrome.
    Saad ST; Vassallo J; Arruda VA; Lorand-Metze I
    Pathologica; 1994 Feb; 86(1):47-51. PubMed ID: 8072801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiogenesis in relation to clinical stage, apoptosis and prognostic score in myelodysplastic syndromes.
    Lundberg LG; Hellström-Lindberg E; Kanter-Lewensohn L; Lerner R; Palmblad J
    Leuk Res; 2006 Mar; 30(3):247-53. PubMed ID: 16099505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological analysis of myelodysplastic syndrome according to French-American-British classification.
    Ehsan A; Aziz M; Arif S; Asif MJ; Ammar T; Riaz Shah SS
    J Coll Physicians Surg Pak; 2010 May; 20(5):313-6. PubMed ID: 20642923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiogenesis in myelodysplastic syndromes (MDS) in Indian patients.
    Dutta P; Bhattacharya J; Karak AK; Gupta M; Chatterjee T; Srinivas U; Mishra P; Saxena R
    Indian J Pathol Microbiol; 2006 Apr; 49(2):218-20. PubMed ID: 16933718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of myeloid and lymphoid markers on the surface and in the cytoplasm of mononuclear bone marrow cells in patients with myelodysplastic syndrome.
    Schlesinger M; Silverman LR; Jiang JD; Yagi MJ; Holland JF; Bekesi JG
    J Clin Lab Immunol; 1996; 48(4):149-66. PubMed ID: 9819667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low blast count myeloid disorders with Auer rods: a clinicopathologic analysis of 9 cases.
    Willis MS; McKenna RW; Peterson LC; Coad JE; Kroft SH
    Am J Clin Pathol; 2005 Aug; 124(2):191-8. PubMed ID: 16040288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Myelodysplastic syndromes: characterization of a series of 56 patients classified according to FAB criteria].
    del Cañizo MC; San Miguel JF; Gascón A; Rios A; Moraleda JM; González M; Anta JP; Sánchez J; López Borrasca A
    Sangre (Barc); 1987; 32(4):436-44. PubMed ID: 3660181
    [No Abstract]   [Full Text] [Related]  

  • 20. Oxidative DNA damage in bone marrow cells of patients with low-risk myelodysplastic syndrome.
    Novotna B; Bagryantseva Y; Siskova M; Neuwirtova R
    Leuk Res; 2009 Feb; 33(2):340-3. PubMed ID: 18687469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.